Author

A. Sedgwick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1

Frequent Co-Authors

C. D'Souza-Schorey· 1 shared C. Guo· 1 shared C. Landaverde· 1 shared H. Balinda· 1 shared J. Nice· 1 shared N. A. Atai· 1 shared S. J. Gould· 1 shared S. J. Tsai· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. D'Souza-Schorey

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mechanisms underlying melanoma invasion as a consequence of MLK3 loss

H. Balinda, A. Sedgwick, C. D'Souza-Schorey

This study identifies MLK3 loss as promoting melanoma invasion through ERK hyperactivation and downstream effects on c-Jun, JNK, and MT1-MMP.

bioRxiv · Dec 10, 2021Cell Biology

Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination

S. J. Tsai, C. Guo, A. Sedgwick, S. Kanagavelu, J. Nice, S. Shetty, C. Landaverde, N. A. Atai, S. J. Gould

This paper develops exosome-based mRNA vaccines that express SARS-CoV-2 antigens, showing long-lasting immune responses and fewer adverse effects than lipid nanoparticles.

bioRxiv · Nov 6, 2020 · PreprintImmunology